Volume 42 Issue 6
Nov.  2021
Turn off MathJax
Article Contents
Xiaochun Xie, Jian-Bao Han, Guanqin Ma, Xiao-Li Feng, Xiaohong Li, Qing-Cui Zou, Zhong-Hua Deng, Jianxiong Zeng. Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies. Zoological Research, 2021, 42(6): 789-791. doi: 10.24272/j.issn.2095-8137.2021.343
Citation: Xiaochun Xie, Jian-Bao Han, Guanqin Ma, Xiao-Li Feng, Xiaohong Li, Qing-Cui Zou, Zhong-Hua Deng, Jianxiong Zeng. Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies. Zoological Research, 2021, 42(6): 789-791. doi: 10.24272/j.issn.2095-8137.2021.343

Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies

doi: 10.24272/j.issn.2095-8137.2021.343
Funds:  This work was supported by start-up funding from the Kunming Institute of Zoology, Chinese Academy of Sciences to J.X.Z.
  • Received Date: 2021-09-29
  • Accepted Date: 2021-10-19
  • Available Online: 2021-10-21
  • Publish Date: 2021-11-18
  • loading
  • [1]
    Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, et al. 2021. SARS-CoV-2 variants, spike mutations and immune escape. Nature Reviews Microbiology, 19(7): 409−424. doi: 10.1038/s41579-021-00573-0
    [2]
    Mlcochova P, Kemp S, Dhar MS, Papa G, Meng B, Ferreira IATM, et al. 2021. SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion. Nature,doi: 10.1038/s41586-021-03944-y.
    [3]
    Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, et al. 2021. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature, 596(7871): 276−280. doi: 10.1038/s41586-021-03777-9
    [4]
    Uriu K, Kimura I, Shirakawa K, Takaori-Kondo A, Nakada TA, Kaneda A, et al. 2021. Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera. bioRxiv,doi: 10.1101/2021.09.06.459005.
    [5]
    Wang CD, Wang ZF, Wang GY, Lau JYN, Zhang K, Li WM. 2021. COVID-19 in early 2021: current status and looking forward. Signal Transduction and Targeted Therapy, 6(1): 114. doi: 10.1038/s41392-021-00527-1
  • ZR-2021-343 Supplementary Materials.pdf
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Article Metrics

    Article views (415) PDF downloads(123) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return